Maximise product value through Medical Insights

The healthcare industry is at an inflection point with constant pressure on margins and limited opportunities to maximise asset value from highly complex technologies such as CAR-T and mRNA.

Medical Insights is emerging as a transformative organisational capability within Medical Affairs that aims to capture real-world insights through medical channels and use them to maximise product and portfolio value.

At Deallus, we believe that intelligence and insights are capabilities that are continuously evolving and remain a critical element for adapting an organisation towards upcoming market events, for building resilience, driving competitive readiness, and enhancing asset strategic planning.

Typically, Medical Insights value proposition covers:

Harnessing cross functional capabilities to generate insights through medical channels
Articulation of clinical, humanistic, and financial insights to maximise product value
Capturing real-world insights from MSL, MI, and clinical development teams
Identifying evidence gaps and assess mitigation plans during strategic planning
Supporting evidence generation enablement and cataloging
Supplementing RWE data used within commercialisation through field insights and enhancing partnerships for evidence generation

Download to read more.

DOWNLOAD PAPER

World Immunization Week 2024

admin2024-04-23T13:03:37+01:00

Decades of transformation, fueled by unprecedented innovation are continuously pushing the bar for what the vaccines industry needs to deliver. A tight balance of public and global health commitments, and commercial attractiveness.

Unlocking Insights at PharmaCI: A Recap from Deallus

admin2024-04-22T11:47:30+01:00

At Deallus, we constantly strive to immerse ourselves in the latest developments and conversations within the competitive intelligence (CI) landscape. Recently, we had the privilege of attending PharmaCI in Munich, where we engaged in enriching discussions with esteemed clients, peers, and colleagues.

Can AI really help you understand what matters in your market?

admin2024-03-19T11:02:30+00:00

The impact of AI across our industry will be profound. It’s already driving faster identification of novel drug targets and drug discovery, better patient identification, accelerated drug development, earlier diagnosis, and more personalized healthcare.